2023 annual financial data
Aclaris Therapeutics 2023 Operating margin
Direct answer
Operating margin was -311.55%.
Operating income was -97,357,000 USD and net income was -88,481,000 USD.
Operating cash flow was -78,325,000 USD.
Get free Aclaris Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 31,249,000 USD
- Operating income
- -97,357,000 USD
- Net income
- -88,481,000 USD
- Operating cash flow
- -78,325,000 USD